Amyris and Total launch “interim” joint venture as they advance towards renewable diesel and jet fuel.
Tweet Total elects to bottle up the IP and protect itself against Amyris “hardship” as it advances towards commercializing key biofuels. In California and France, Amyris and Total announced the formation of Total Amyris BioSolutions B.V., a 50-50 joint venture that now holds exclusive rights and a license under Amyris’s intellectual property to produce and […]
Tweet In California, Amyris announced that Paulo Diniz, currently President of Amyris Brasil, will become Amyris’s Chief Financial Officer on an interim basis following the decision of its current CFO, Steve Mills, to step down for personal reasons. Diniz will previously CFO at Bunge Brasil and Cosan. At Cosan, Mr. Diniz led the successful transformation […]
Tweet SZYM, AMRS, GEVO check in with Q3 results. What’s heavenly, what’s hellish? Yep, what’s up at the crossroads of advanced fermentation, synthetic biology, and the markets in big-league fuels, chemicals, fragrances and flavorings — as the three reach for scale? In years gone by, it was not too hard to write up a summary […]
Tweet In New York, Rob Stone and James Medvedeff of Cowen & Company wrote of Amyris’ Q3 results: “Q3:13 26¢ cash loss was narrower than St. (30¢) on other income, but revenue was 48% light, GM negative, and Q4 product sales trimmed. Partner funding adds cash in Q4, but only half of 2014 is contracted….Cost […]
Tweet In California, Amyris announced its highest farnesene production volumes at the lowest quarterly unit costs to date, as part of its third quarter financial results package. “We expect continued growth in 2014 in new areas such as lubricants, specialty fluids and polymers,” said John Melo, Amyris President & CEO, who confirmed that “we are […]
Tweet From the leaders in bioenergy and chemicals— the real issues and trends, as seen at ABLC In California, ABLC-Next has concluded for this year, and it is time to continue the review from a convergence of advanced biofuels leadership in R&D, commercialization, policy and finance. That will reconvene at ABLC 2014 — the Advanced […]
Tweet Biobased investing continues surging, both direct and via strategics. The Digest has the data and the scoop in our 5-Minute Guide. In Florida, Biofuels Digest reports that 9 biobased ventures raised $363.8 million in new capital in 2013, compared to $435 million in Q2, and $434 million in Q4 2012 and Q1 2013. Overall, […]
Tweet In California, Amyris has secured a $35 million bridge loan at 5.5% interest from current investor Maxwell (Mauritius) Pte. The promissory note matures on February 2. The annual percentage rate is equivalent to 16.5% but should the company default on the note, the interest rate goes to 2% per month or 24% per year.
Tweet Record renewable products sales, but slow ramp up, for farnesene: how does the future shape up for Amyris? In California, Amyris last week announced $10.8M in Q2 2013 revenue, compared to $19.3M in Q2 2012 (before the company transitioned out of the ethanol business). $4.2M was related to renewable product sales and $6.7M in […]
Tweet In California, Amyris announced it entered into agreement for the sale of convertible notes in a private placement for up to $60 million in cash proceeds. Under the terms of the agreement, one of Amyris’s largest stockholders, Temasek, agreed to purchase $35 million of the notes in an initial tranche and, at Amyris’s election, up […]